Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company primarily focused on developing innovative immunotherapies to combat cancer.

52W Range

9thpctl

Volume

0.82×avg

Market Cap

32.45MUSD

P/E Ratio

-0.3TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

BriaCell Therapeutics Corp.

BCTXNASDAQ Capital Market·USD·Closed

BriaCell Therapeutics Corp.

BCTXNASDAQ·USD·Closed

$3.73

+0.54%

$3.73

+$0.02 (0.54%)

52W Range

9thpctl

Volume

0.82×avg

Mkt Cap

32.45MUSD

P/E

-0.3TTM

Div Yield

–ann

BCTX: BriaCell Therapeutics Corp. Stock Analysis | finqOS